Skip to content
Wednesday, July 15, 2026

Ayen News

Democratizing information: Free world-class API and RSS feeds for every business.

  • Business
  • National
  • International
  • Crime
  • Technology & AI
  • Health & Science
  • Legal
  • Sports
  • Fact Check
  • Blog

Tag: Ozempic

  • Home
  • Ozempic
  • Health & Science

GLP-1 Drugs Like Ozempic Are Opening the Door to a New Era of Obesity Treatment — Expert Review

  • June 29, 2026
  • 0

A comprehensive review says the success of semaglutide and tirzepatide is not just about weight loss but signals a paradigm shift in how metabolic disease is approached.

  • Health & Science

Ozempic and Wegovy Linked to a Surprising Drop in Impulsive Violent Behavior — Rutgers Study

  • June 29, 2026
  • 0

GLP-1 receptor agonists like semaglutide appear to weaken the link between impulsive tendencies and violent behavior opening a potential new application in mental health.

  • Blog

Opinion: Why GLP-1 Sales Haven’t Taken Off Despite Enormous Potential — Zerodha’s Kamath Wonders Too

  • June 29, 2026
  • 0

Zerodha co-founder Nikhil Kamath takes to X to question why obesity drugs like Ozempic are still underperforming in India despite strong international buzz.

  • Health & Science

Semaglutide Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss Than Other Interventions

  • June 26, 2026
  • 0

GLP-1 receptor agonist drugs appear to have bone-protective effects potentially through preservation of lean muscle mass during weight loss.

  • Health & Science

Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Medication Within a Year

  • June 26, 2026
  • 0

New real-world data shows high rates of GLP-1 reinstatement driven by weight regain and return of metabolic health concerns after stopping.

  • Health & Science

Ozempic and Wegovy Linked to Surprising Drop in Violent Behavior in New Research Analysis

  • June 26, 2026
  • 0

New study suggests GLP-1 receptor agonists may reduce impulsive aggression through effects on brain reward and impulse control systems.

  • Health & Science

Ozempic and Wegovy Linked to Surprising Drop in Violent Behavior in Rutgers Study

  • June 25, 2026
  • 0

Rutgers researchers found that GLP-1 drugs may weaken the link between impulsive tendencies and violent behaviour, though researchers stress causation not proven.

  • Health & Science

Ozempic Changed Obesity Treatment Landscape and Experts Say the Real GLP-1 Revolution Is Next

  • June 23, 2026
  • 0

The success of semaglutide has opened the door to a new era of combination therapies minimally invasive procedures and next-generation GLP-1 receptor agonists.

  • Health & Science

Ozempic and Wegovy Linked to Surprising Reduction in Violent Behaviour

  • June 18, 2026
  • 0

A Rutgers University study found that GLP-1 receptor agonist drugs like Ozempic and Wegovy may reduce the link between impulsive tendencies and violent acts.

  • Blog

Why GLP-1 Drugs Like Ozempic May Be the Most Surprising Crime-Fighters of Our Time

  • June 18, 2026
  • 0

A new Rutgers study links Ozempic and Wegovy to reduced violent impulses — opinion writers weigh the ethical and social implications.

Posts pagination

1 2 Next

Recent Posts

  • California’s Claude discount deal called the largest state AI deployment in US history
  • Edge226 acquires AnyClip to strengthen AI-powered video marketing
  • QuadSci named Machine Learning Company of the Year
  • Profound launches ‘Aim,’ an always-on AI marketing intelligence agent
  • Cursor discounts Composer 2.5 usage by 75% through July 5

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026

Categories

  • Blog
  • Business
  • Crime
  • Fact Check
  • Health & Science
  • International
  • Legal
  • National
  • Sports
  • Technology & AI

Important Links

News Disclaimer | RSS Feeds | Learn more about Ayen

Copyright © 2026 Ayen News - Click here for API access. Theme: Gateway News By Adore Themes.